Developing new diagnostic system for the early detection of cancer metastasis and monitoring the response to therapy. The technical and clinical development program is funded by a grant over 3 years from the National Institute of Health Research to a value of £48,000. The investment allows us to build our commercial team in parallel and launch the product faster than we could achieve otherwise.